PNC FINANCIAL SERVICES GROUP, INC. - PEREGRINE PHARMACEUTICALS IN ownership

PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 79 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of PEREGRINE PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$1,0000.0%1,0000.0%0.00%
Q1 2017$1,0001,0000.0%0.00%
Q4 2016$01,0000.0%0.00%
Q3 2016$01,0000.0%0.00%
Q2 2016$01,0000.0%0.00%
Q1 2016$0
-100.0%
1,0000.0%0.00%
Q4 2015$1,0000.0%1,0000.0%0.00%
Q3 2015$1,0001,000
+2400.0%
0.00%
Q3 2014$0
-100.0%
40
-99.3%
0.00%
Q2 2014$11,0000.0%6,040
+0.7%
0.00%
Q1 2014$11,0006,0000.00%
Other shareholders
PEREGRINE PHARMACEUTICALS IN shareholders Q2 2016
NameSharesValueWeighting ↓
TWO SIGMA SECURITIES, LLC 67,228$88,0000.15%
Freedom Investment Management, Inc. 534,390$700,0000.07%
BAXTER BROS INC 135,506$178,0000.06%
SABBY MANAGEMENT, LLC 67,578$1,533,0000.06%
Sterling Global Strategies LLC 10,000$13,0000.04%
SMITH ASSET MANAGEMENT GROUP LP 870,750$1,141,0000.04%
FIDGEON TIMOTHY F 60,000$78,0000.04%
First Heartland Consultants, Inc. 86,204$113,0000.03%
Rotella Capital Management, Inc. 25,269$33,0000.03%
CORRADO ADVISORS, LLC 15,000$20,0000.01%
View complete list of PEREGRINE PHARMACEUTICALS IN shareholders